FDA approves LyricaÃâ for the treatment of two common forms of neuropathic pain
Wednesday, July 30th, 2008Pfizer Inc said today that it have received delight from the U.S. Food and Drug Administration (FDA) to open market LyricaTM (pregabalin capsules) in leg of the guidance of neuropathic agony associated beside diabetic divergent neuropathy (DPN) and postherpetic neuralgia (PHN). Lyrica be the most basic FDA-approved nursing for both of these neuropathic […]

